Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $11.93 USD
Change Today -0.06 / -0.50%
Volume 780.0K
As of 8:10 PM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Robert Repella R.Ph.,MBA

AgeTotal Calculated CompensationThis person is connected to 29 board members in 1 different organizations across 4 different industries.

See Board Relationships
As of Fiscal Year 2014


Mr. Robert Repella, also known as Bob, R.Ph., MBA. has been Executive Vice President of Global Commercial Operations at CSL Behring LLC since 2014. Mr. Repella has been Executive Vice President of Global Commercial Operations at CSL Ltd. since joining in July 1, 2014. He is responsible for a variety of global functions including sales, marketing, commercial development and medical affairs. Mr. Repella has over 30 years of commercial experience including biotech and specialty ...

Read Full Background

Corporate Headquarters*

2200 Pennsylvania Avenue NW
Washington, District Of Columbia 20037

United States

Phone: 202-734-3400
Fax: 202-296-1450

Board Members Memberships*



Bachelor's Degree
Rutgers, The State University of New Jersey
Temple University

Other Affiliations*

Annual Compensation*

Total Annual Compensation$955,569

Stock Options*

Restricted Stock Awards$418,158
Long Term Incentive Plan$42,075
All Other Compensation$54,050
Unexercisable Options22,312
Total Number of Options22,312

Total Compensation*

Total Annual Cash Compensation$1,009,619
Total Short Term Compensation$955,569
Other Long Term Compensation$472,208
Total Calculated Compensation$1,512,803
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
VNDA:US $11.93 USD -0.06


Jean-Pierre Clamadieu Chief Executive Officer, Director and Member of Finance Committee
Solvay SA
Flemming Ornskov M.D., MBA, MPHChief Executive Officer, Managing Director and Director
Shire plc
Victor Grifols Roura Chairman, Chief Executive Officer, President and Member of Appointments & Remuneration Committee
Grifols, S.A.
Yoshihiko Hatanaka Chief Executive Officer, President and Representative Director
Astellas Pharma, Inc.
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VANDA PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at